Diagnostic usefulness of testing for anti‐HBc IgM in acute hepatitis B
Karen L. Lindsay, J. Anne Nizze, Ronald Koretz, Gary Gitnick – 1 November 1986 – Numerous tests to detect anti‐HBc IgM have been developed and shown to have different degrees of sensitivity and specificity. One of these assays, Corzyme®‐M (Abbott Laboratories, North Chicago, Ill.), recently became commercially available. The present study was undertaken to evaluate the clinical utility of this anti‐HBc IgM test in establishing the diagnosis of acute hepatitis B using sera from a group of 42 prospectively followed individuals who had been exposed to hepatitis B virus.